These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Booster COVID-19 vaccination against the SARS-CoV-2 Omicron variant: A systematic review. Du Y; Chen L; Shi Y Hum Vaccin Immunother; 2022 Nov; 18(5):2062983. PubMed ID: 35499517 [TBL] [Abstract][Full Text] [Related]
24. Antibody affinity and cross-variant neutralization of SARS-CoV-2 Omicron BA.1, BA.2 and BA.3 following third mRNA vaccination. Bellusci L; Grubbs G; Zahra FT; Forgacs D; Golding H; Ross TM; Khurana S Nat Commun; 2022 Aug; 13(1):4617. PubMed ID: 35941152 [TBL] [Abstract][Full Text] [Related]
25. A comprehensive analysis of the efficacy and effectiveness of COVID-19 vaccines. He X; Su J; Ma Y; Zhang W; Tang S Front Immunol; 2022; 13():945930. PubMed ID: 36090988 [TBL] [Abstract][Full Text] [Related]
26. Systematic review and meta-analysis of the factors affecting waning of post-vaccination neutralizing antibody responses against SARS-CoV-2. Jacobsen H; Sitaras I; Katzmarzyk M; Cobos Jiménez V; Naughton R; Higdon MM; Deloria Knoll M NPJ Vaccines; 2023 Oct; 8(1):159. PubMed ID: 37863890 [TBL] [Abstract][Full Text] [Related]
27. Strong Correlations between the Binding Antibodies against Wild-Type and Neutralizing Antibodies against Omicron BA.1 and BA.2 Variants of SARS-CoV-2 in Individuals Following Booster (Third-Dose) Vaccination. Suntronwong N; Assawakosri S; Kanokudom S; Yorsaeng R; Auphimai C; Thongmee T; Vichaiwattana P; Duangchinda T; Chantima W; Pakchotanon P; Chansaenroj J; Nilyanimit P; Srimuan D; Thatsanatorn T; Sudhinaraset N; Wanlapakorn N; Mongkolsapaya J; Poovorawan Y Diagnostics (Basel); 2022 Jul; 12(8):. PubMed ID: 35892491 [TBL] [Abstract][Full Text] [Related]